KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Vertex Pharmaceuticals (VRTX) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Vertex Pharmaceuticals (VRTX) over the last 14 years, with Q3 2022 value amounting to $256.6 million.

  • Vertex Pharmaceuticals' Shares Outstanding rose 15.61% to $256.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $256.6 million, marking a year-over-year increase of 15.61%. This contributed to the annual value of $254.5 million for FY2021, which is 207.77% down from last year.
  • According to the latest figures from Q3 2022, Vertex Pharmaceuticals' Shares Outstanding is $256.6 million, which was up 15.61% from $256.0 million recorded in Q2 2022.
  • Vertex Pharmaceuticals' 5-year Shares Outstanding high stood at $260.2 million for Q3 2020, and its period low was $254.5 million during Q4 2021.
  • In the last 5 years, Vertex Pharmaceuticals' Shares Outstanding had a median value of $256.6 million in 2022 and averaged $257.2 million.
  • Per our database at Business Quant, Vertex Pharmaceuticals' Shares Outstanding skyrocketed by 240.15% in 2018 and then crashed by 207.77% in 2021.
  • Vertex Pharmaceuticals' Shares Outstanding (Quarter) stood at $255.2 million in 2018, then increased by 1.49% to $259.0 million in 2019, then increased by 0.35% to $259.9 million in 2020, then dropped by 2.08% to $254.5 million in 2021, then rose by 0.83% to $256.6 million in 2022.
  • Its last three reported values are $256.6 million in Q3 2022, $256.0 million for Q2 2022, and $255.6 million during Q1 2022.